5,6-dihydroxytryptamine has been researched along with 1-(3-chlorophenyl)piperazine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Broch, OJ; Eide, PK; Hole, K | 1 |
Bortel, A; Brus, R; Dabrowska, J; Drosik, M; Kostrzewa, RM; Kwiecinski, A; Nowak, P; Opara, J; Oswiecimska, J | 1 |
2 other study(ies) available for 5,6-dihydroxytryptamine and 1-(3-chlorophenyl)piperazine
Article | Year |
---|---|
Supersensitivity to the antinociceptive effect of a 5-HT1 receptor agonist after lesion of raphe-spinal serotonergic neurones.
Topics: 5,6-Dihydroxytryptamine; Animals; Injections, Spinal; Male; Mice; Motor Activity; Neurons; Piperazines; Raphe Nuclei; Receptors, Serotonin; Serotonin; Skin Temperature; Spinal Cord; Sympathectomy, Chemical | 1992 |
Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,6-Dihydroxytryptamine; Age Factors; Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Hydroxyindoleacetic Acid; Male; Microdialysis; Oxidopamine; Piperazines; Pregnancy; Rats; Rats, Wistar; Serotonin; Serotonin Receptor Agonists; Sympatholytics | 2007 |